POINT Biopharma Completes Enrollment in Phase 3 Trial of PNT2002 to Treat Prostate Cancer; Shares Rise
POINT Biopharma Completes Enrollment in Phase 3 Trial of PNT2002 to Treat Prostate Cancer; Shares Rise
POINT Biopharma 完成了治疗前列腺癌的 PNT2002 三期试验的注册;股价上涨
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册